Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta‐analysis
Authors:
- 2 September 2015
- journal article
- review article
- Published by Wiley in Hepatology Research
- Vol. 46 (1) , 58-71
Abstract
Aim: To investigate the efficacy and safety of radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE) for treatment of patients with hepatocellular carcinoma (HCC).Methods: All eligible studies were collected from PubMed, the Cochrane Libraries and Embase. The evaluation indices included overall survival (OS) rate, recurrence‐free survival rate, local tumor progression rate and major complications. All statistical analysis was performed by RevMan version 5.2 software.Results: There were 21 studies with 3073 patients included in this meta‐analysis. The RFA monotherapy was associated with higher 3‐ and 5‐year OS rates (OR3‐year = 2.33, 95% confidence interval [CI] = 1.34–4.05; OR5‐year = 2.05, 95% CI = 1.48–2.85) compared with TACE alone. The combination of RFA and TACE was associated with higher 1‐, 3‐ and 5‐year OS rates (OR1‐year = 1.94, 95% CI = 1.28–2.96; OR3‐year = 1.56, 95% CI = 1.19–2.04; OR5‐year = 1.53, 95% CI = 1.13–2.07) compared with RFA alone.Conclusion: The combination of TACE with RFA could obviously improve the short‐ and long‐term survival rates and significantly provide a better prognosis for patients with intermediate‐size HCC. RFA was associated with a higher long‐term OS rate than that of TACE‐treated patients with HCC.Keywords
This publication has 47 references indexed in Scilit:
- Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinomaHepatology Research, 2013
- Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized TrialJournal of Clinical Oncology, 2013
- Hepatocellular carcinomas 2–3cm in diameter: Transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation aloneEuropean Journal of Radiology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort studyHepatology, 2010
- Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysisLiver International, 2010
- A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2010
- Transarterial Injection of 131I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular CancerJournal of Nuclear Medicine, 2009
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003